{"schema_version":"secwatch.filing_event.v1","accession":"0001550695-24-000040","form_type":"8-K","ticker":null,"cik":"0001550695","company_name":"Performant Healthcare Inc","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.925142+00:00","generated_at":"2026-06-02T18:06:59.256959+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Performant Q1 healthcare rev up 13% to $25.8M; net loss narrows to $4.0M; reaffirms FY24 guidance","bullets":["Healthcare revenue $25.8M (+13% YoY); total revenue $27.3M (+6% YoY).","Net loss of $4.0M ($0.05/sh) vs $4.2M ($0.06/sh) prior year; adjusted net loss $3.0M.","Adj. EBITDA improved to $(1.2)M from $(1.7)M prior year.","Reaffirmed FY2024 guidance: healthcare rev $117-122M, total rev $124-129M, adj EBITDA $4-5M.","Acquired AI technology from RecordsOne in April; 10 commercial programs implemented in Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001550695-24-000040","json":"https://secwatch.observer/filing/0001550695-24-000040.json","markdown":"https://secwatch.observer/filing/0001550695-24-000040.md","text":"https://secwatch.observer/filing/0001550695-24-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/0001550695-24-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/pfmt-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T18:06:59.256959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"956699648bf37e97ececdac8526455f2abb61f99","claim":"Performant Healthcare Inc reported first quarter ended March 31, 2024 results: revenue $27.3 million, net income $(0.05) per diluted share. Guidance reaffirmed.","evidence_excerpt":"Quarter Financial Highlights • Healthcare revenues of $25.8 million, compared to $22.9 million in the prior year period, an increase of approximately 13%. • Total revenues of $27.3 million, compared to total revenues of $25.7 million in the prior year period. • Net loss of $4.0 million, or $(0.05) per diluted share, compared to net loss of $4.2 million, or $(0.06)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1550695/000155069524000040/0001550695-24-000040-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$27.3 million"},{"label":"Net income","value":"$(0.05) per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}